Ping An Biomedical Raises $4 Million in Private Share Placement

Ping An Biomedical ( (PASW) ) has shared an update.

On February 9, 2026, Ping An Biomedical Co., Ltd. entered into securities purchase agreements with accredited and certain non-U.S. investors for a private placement of 100,000,000 ordinary shares at $0.04 per share, raising an aggregate of $4 million. The offering, structured under exemptions from U.S. registration requirements with transfer restrictions on the new shares, positions the company to bolster its capital base without a public offering, with closing expected within three business days of signing the agreements.

The transaction reflects Ping An Biomedical’s continued reliance on private capital markets to support its operations and growth, while existing and new investors assume the constraints of unregistered securities that cannot be freely resold in the United States. By avoiding general solicitation and targeting accredited and non-U.S. buyers, the company adheres to U.S. securities regulations, potentially improving its financial flexibility while limiting immediate liquidity for participants in the deal.

More about Ping An Biomedical

Ping An Biomedical Co., Ltd. is a Cayman Islands–incorporated company listed on the Nasdaq Capital Market, operating in the biomedical sector. The company issues ordinary shares with a par value of $0.0000625 per share and accesses international capital markets through private placements to fund its business activities.

Average Trading Volume: 3,652,281

Technical Sentiment Signal: Strong Sell

Current Market Cap: $6.24M

See more data about PASW stock on TipRanks’ Stock Analysis page.